Search Results - Michael H. Pillinger

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    New perspectives on the NLRP3 inflammasome—colchicine and the suppression of inflammatory pathways in metabolic syndrome associated diseases by Benjamin Plotz, Michael Toprover, Robert T. Keenan, Michael H. Pillinger

    Published in Exploration of Musculoskeletal Diseases (2025-09-01)
    Get full text
    Article


  2. 2

    Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model by Jaymin Shah, Michael H. Pillinger, Elaine K. Chan, Dmitri Lissin

    Published in Rheumatology and Therapy (2025-06-01)
    Get full text
    Article


  3. 3

    How URAT1 inhibitors can shape the future of chronic gout treatment: a narrative review of uricosurics past and present by Robert T. Keenan, Zancong Shen, Shunqi Yan, Li-Tain Yeh, Michael H. Pillinger

    Published in Exploration of Musculoskeletal Diseases (2024-12-01)
    Get full text
    Article


  4. 4

    Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis by Vibeke Strand, Michael H. Pillinger, Abiola Oladapo, Charis Yousefian, Dani Brooks, Nana Kragh

    Published in Rheumatology and Therapy (2024-08-01)
    Get full text
    Article


  5. 5

    Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE‐PCI Biomarker Substudy by Nina Talmor, Michael H. Pillinger, Yuhe Xia, Ana Leonard, Fatmira Curovic, Binita Shah

    Get full text
    Article


  6. 6

    Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel by Daniel H. Solomon, Joel S. Weissman, Hyon Choi, Steven J. Atlas, Cesar Berardinelli, Julien Dedier, Michael A. Fischer, John Fitzgerald, Erica Hinteregger, Brianne Johnsen, Diana D. Marini, Robert McLean, Fred Murray, Tuhina Neogi, Lynn B. Oertel, Michael H. Pillinger, Kevin R. Riggs, Ken Saag, Dong Suh, James Watkins, Michael J. Barry

    Published in ACR Open Rheumatology (2021-05-01)
    Get full text
    Article


  7. 7

    The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms by Daniel H. Solomon, Misti Paudel, Shravani Chitineni, Ana Fernandes, Tammy Pham, Shreya Billa, Chio Yokose, Kiara Tan, Julien J. Dedier, Maureen D. Dubreuil, John D. Fitzgerald, Sally L. Hodder, Tuhina Neogi, Michael H. Pillinger, Kevin R. Riggs, Kenneth G. Saag, Paul G. Shekelle, Zoe Tseng, Michael Toprover, David S. Wei, Michael J. Barry, Hyon K. Choi

    Published in ACR Open Rheumatology (2025-03-01)
    Get full text
    Article


Search Tools: